News for ShockWave Medical, Inc. (SWAV)

Market News Alerts Reports: Inspira Technologies (NASDAQ: IINN)* is reported beginning deployment of its FDA-cleared INSPIRA ART100 system at a leading New Yor

[url="]Extreme Networks, Inc.[/url] (Nasdaq: EXTR), a leader in AI-powered automation for networking, today announced it has appointed Anisha Vaswani as Chief

J&J tops earnings estimates amid strong demand for cancer treatments

J&J beats quarterly sales and profit estimates on cancer drug sales

Johnson & Johnson's 'AAA' rating on Credit Watch Negative at S&P following Intra-Cellular Therapies acquisition

J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion

Healthcare executives expect more IPOs and corporate dealmaking in 2025

We recently made a list of Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks.

Post Kenvue spin, the company is deciding to use cash to further diversify their MedTech offerings. Explore more details here.

We recently compiled a list of the 10 Best Magic Formula Stocks For The Rest Of 2024. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other magic...

One of the best known investment strategies on Wall Street, and one that's also followed by investing greats the like of Warren Buffett of Berkshire Hathaway and Seth Klarman of Baupost Group is value...

With the latest round of 13F filings released over the past month, investors and market watchers alike are interested in seeing where the major hedge fund manag

Kevin Ballinger and Mitch Hill appointed as new independent Board members...

Baron Health Care Fund declined in the second quarter of 2024, lagging its primary benchmark, the Russell 3000 Health Care Index.

The rising challenge of antibiotic-resistant infections is a major factor driving growth in the antibiotic-resistance market. Additionally, the growing...

Earnings call: Johnson & Johnson sees growth amid challenges

Although many equity markets slipped in January, they recovered over the next two months for a strong first quarter of 2024.

BALA CYNWYD, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...

During the first quarter, Baron Opportunity Fund rose 15.33%, outperforming the broader market, including the Russell 3000 Growth Index.